Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Dermatophytes, like Trichophyton rubrum, can cause allergies and chronic inflammation.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

Gefitinib can cause rare scarring hair loss.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Trichohyalin may trigger the immune response causing alopecia areata.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Leflunomide and anthralin may effectively treat severe alopecia areata.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Thorough scalp examination is crucial for diagnosing alopecia areata incognita in men with diffuse hair loss.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.

The cause of the syndrome with scalp scaling and hair loss is unknown.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Topical 1% pimecrolimus effectively treated alopecia areata.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Demodicosis should be considered in cats with facial skin issues exposed to inhalant glucocorticoids.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.